MAKE TECVAYLI® THE 1st-CHOICE BISPECIFIC ANTIBODY FOR YOUR APPROPRIATE PATIENTS1

Blue monoclonal antibody iconBlue monoclonal antibody icon

RRMM, relapsed or refractory multiple myeloma.

References:

  1. TECVAYLI® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.
  2. Data on file. Janssen Biotech, Inc.
Yellow monoclonal antibody icon

Discover a unique mechanism of action

Arrow icon
cta icon

Register to stay up-to-date with important information about TECVAYLI®

Sign Up
Email icon

Connect with a representative from Johnson & Johnson

Get in Touch
Stacked books icon

Access resources to help patients receive TECVAYLI®

Explore Resources
Chat bubble iconChat bubble icon

Need help?

Chat With Medical Information